How a membrane lipid tunes the eye's response to light
Weill Cornell Medicine investigators have determined how a molecule within cells can help tune the eyes' sensitivity to light. The study identified the molecule's binding site on a protein in retinal cells, which should enable the development of drugs that target the site to treat related eye diseases.
Researchers from Weill Cornell Medicine have discovered how a molecule called PIP2 in retinal cells helps regulate the eye's sensitivity to light. Published in Nature Communications, the study identifies the specific binding site on a protein in rod cells that PIP2 inhibits, potentially leading to new treatments for eye diseases.
PIP2, a phospholipid found in most human cells, typically exists at very low concentrations in rod-cell membranes, making it difficult to study. Using model membranes and high-resolution imaging, the researchers determined that PIP2 binds to a specific site on CNG channels (a key ion channel) in rod cells, inhibiting their activity.
This binding helps regulate light sensitivity, particularly in low-light conditions, and could be a target for drug development to treat eye diseases caused by defective CNG channels. Understanding this mechanism also has clinical implications for retinal degeneration and vision loss.
Written by urgent.news from Medical Xpress's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
